Adverse events of combined Dabrafenib Plus Trametinib in the treatment of tumors: a systematic review and meta-analysis.
Not Applicable
- Conditions
- tumors
- Registration Number
- JPRN-UMIN000041453
- Lead Sponsor
- 3-9 Fukuura, Kanazawa, Yokohama 236-0004, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Without frequency or category of adverse event
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method category fo adverse event
- Secondary Outcome Measures
Name Time Method frequency of adverse event